EVM
CELL

Eaton Vance Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Eaton Vance Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$57K Hold
20,024
– – ﹤0.01% 1528
2022
Q2 		$100K Sell
20,024
-6,707
-25% -$35.1K ﹤0.01% 1545
2022
Q1 		$190K Hold
26,731
– – ﹤0.01% 1758
2021
Q4 		$486K Hold
26,731
– – ﹤0.01% 1338
2021
Q3 		$523K Buy
26,731
+14,346
+116% +$546K ﹤0.01% 1211
2021
Q2 		$555K Hold
12,385
– – ﹤0.01% 1323
2021
Q1 		$622K Buy
+12,385
New +$844K ﹤0.01% 1236

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
NIMC
Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return